Stabilizing Cellular Barriers: Raising the Shields Against COVID-19
Endocrinology
[키워드] activate
acute respiratory and circulatory disruption
acute respiratory syndrome
Against
caused
cellular mechanism
Clinical outcome
coronavirus
coronavirus disease
COVID-19
COVID-19 progression
develop
diabetes
disrupt
Disruption
endothelial
endothelial barrier disruption
enteroendocrine
epithelial
Escalation
explain
glucagon like peptide 1 (GLP-1)
Health
immune cells
IMPROVE
lung
mechanism
multi-organ dysfunction
obesity
outcomes
Patient
peptide
pro-inflammatory
progression
respiratory symptoms
risk factor
Risk factors
SARS-CoV-2
SARS-COV-2 infection
severe COVID-19
Shield
Signaling
synergism
therapeutic intervention
tumor necrosis factor (TNF)
tumor necrosis factor converting enzyme (TACE)
underlying condition
[DOI] 10.3389/fendo.2020.583006 PMC 바로가기 [Article Type] Endocrinology
[DOI] 10.3389/fendo.2020.583006 PMC 바로가기 [Article Type] Endocrinology